Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/CIMA-AEMPS/LAVIRK 50 MG/G GEL

Approved

STANDARD

LAVIRK 50 MG/G GEL

Kern Pharma S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Nov 16, 2020
Approval ID: abc3df03db045678
Company: Kern Pharma S.L.
Type: Standard

Approval Details

Approval Id: abc3df03db045678
Drug Cima Aemps Name: LAVIRK 50 MG/G GEL
Register Number: 85563
Holder Company Name: Kern Pharma S.L.
Marketing Company Name: Kern Pharma S.L.
Holder Company Detail Path: /organization/kern-pharma-s-l
Marketing Company Detail Path: /organization/kern-pharma-s-l
Authorization Date: 2020-11-16
Dosage Form: GEL
Dose: 50 mg/g
Route Of Administration: USO CUTÁNEO
Prescription Type: Sin Receta
Commercialized: Yes
Company Name: Kern Pharma S.L.
Company Detail Path: /organization/kern-pharma-s-l

Company Information

Pharmaceutical Company Name: Kern Pharma S.L.
Country Name: Dominican Republic

Active Ingredients

ACICLOVIR

50 mg/g

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 16, 2020

Approval ID

abc3df03db045678

Type

Standard

Back to CIMA-AEMPS Approvals

LAVIRK 50 MG/G GEL - CIMA-AEMPS Drug Approval Details